Methysergide
Top View
- Tihkal: the Continuation, by Alexander and Ann Shulgin
- Quasar, Quantitative Structure Activity Relationships of Analgesics
- Constrictive Pericarditis and Pleuropulmonary Fibrosis Secondary to Cabergoline Treatment for Parkinson’S Disease M Townsend, D H Maciver
- Chronic Pericardial Constriction Linked to the Antiparkinsonian Dopamine Agonist Pergolide K P Balachandran, D Stewart, G a Berg, K G Oldroyd
- Antiserotonin Drugs in Migraine Prophylaxis
- Predictive Value of Parkinsonian Primates in Pharmacological Studies, a Comparison Between the Macaque, Marmoset and Squirrel Monkey I
- Unauthorized Research on Cluster Headache
- Pharmacological Evidence for the Subclassification of Central Dopamine Receptors in the Rat Alma J
- Novel Pharmacological Targets for the Treatment of Parkinson's Disease
- Emergencies and Critical Issues in Parkinson's Disease
- (12) United States Patent (10) Patent No.: US 8,859,579 B2 Sewell (45) Date of Patent: Oct
- Behavioral Tolerance to Lysergic Acid Diethylamide Is Associated with Reduced Serotonin-2A Receptor Signaling in Rat Cortex
- Aggravating Effect of Ergometrine on Pyloric Antral Lesions in Indomethacin-Treated Animals and Stimulating Effect of This Drug on Gastric Acid Secretion
- Response of Cluster Headache to Self-Administration of Seeds Containing Lysergic Acid Amide (Lsa) R
- Poster 1 Xocpharma Final
- Recent Advances in the Neuropsychopharmacology of Serotonergic
- Ergometrine Injection
- Reagents for Lysergic Acid Diethylamide Immunoassay